https://www.selleckchem.com/
The findings supported the long-term impacts of childhood conditions for later life health consequences.Aim New epigenetically based methods for assessing risk for coronary heart disease may be more sensitive but are generally more costly than current methods. To understand their potential impact on healthcare spending, we conducted a cost-utility analysis. Methods We compared costs using the new Epi + Gen CHD™ test with those of existing tests using a cohort Markov simulation model. Results We found that use of the new test was associated with both better
Like
Comment
Share
